Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 20 | 2024 | 1412 | 2.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2024 | 848 | 1.020 |
Why?
|
| Hypoglycemic Agents | 12 | 2022 | 599 | 0.950 |
Why?
|
| Insulin Resistance | 5 | 2021 | 732 | 0.850 |
Why?
|
| Blood Glucose | 15 | 2024 | 1269 | 0.700 |
Why?
|
| Hypoglycemia | 4 | 2022 | 220 | 0.630 |
Why?
|
| Metformin | 4 | 2020 | 393 | 0.620 |
Why?
|
| Hyperglycemia | 4 | 2022 | 337 | 0.610 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 831 | 0.460 |
Why?
|
| Insulin | 7 | 2022 | 1483 | 0.430 |
Why?
|
| Adolescent | 24 | 2024 | 32767 | 0.300 |
Why?
|
| Medication Adherence | 3 | 2020 | 513 | 0.270 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 1034 | 0.260 |
Why?
|
| Peer Group | 1 | 2024 | 141 | 0.220 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 118 | 0.200 |
Why?
|
| Mentors | 1 | 2024 | 210 | 0.200 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 332 | 0.200 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 79 | 0.190 |
Why?
|
| Puberty | 1 | 2021 | 97 | 0.190 |
Why?
|
| Sleep | 1 | 2024 | 442 | 0.180 |
Why?
|
| Self Report | 1 | 2024 | 796 | 0.170 |
Why?
|
| Child | 18 | 2022 | 30559 | 0.160 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 22 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 187 | 0.150 |
Why?
|
| Age of Onset | 1 | 2020 | 853 | 0.150 |
Why?
|
| Quality of Life | 3 | 2024 | 4761 | 0.150 |
Why?
|
| Insurance Coverage | 1 | 2020 | 275 | 0.150 |
Why?
|
| Medicaid | 1 | 2020 | 306 | 0.140 |
Why?
|
| Self Care | 3 | 2024 | 246 | 0.140 |
Why?
|
| Insulin Infusion Systems | 3 | 2022 | 58 | 0.130 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 317 | 0.130 |
Why?
|
| Glucagon | 1 | 2016 | 201 | 0.130 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 180 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 118 | 0.120 |
Why?
|
| Humans | 32 | 2024 | 270740 | 0.120 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2014 | 16 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1024 | 0.110 |
Why?
|
| Depression | 4 | 2016 | 1730 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 75 | 0.110 |
Why?
|
| Family | 2 | 2009 | 783 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2020 | 9470 | 0.100 |
Why?
|
| Biomarkers | 2 | 2024 | 5051 | 0.100 |
Why?
|
| Young Adult | 5 | 2024 | 22251 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 369 | 0.100 |
Why?
|
| Heart Atria | 1 | 2014 | 354 | 0.090 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2023 | 116 | 0.090 |
Why?
|
| Male | 19 | 2024 | 128315 | 0.090 |
Why?
|
| Risk Factors | 6 | 2024 | 17888 | 0.090 |
Why?
|
| Female | 20 | 2024 | 148940 | 0.090 |
Why?
|
| Cysteine | 1 | 2010 | 214 | 0.080 |
Why?
|
| Body Mass Index | 4 | 2021 | 2232 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 847 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2023 | 602 | 0.080 |
Why?
|
| Glutathione | 1 | 2010 | 374 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 322 | 0.080 |
Why?
|
| Parents | 1 | 2015 | 1082 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 233 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2007 | 34 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2009 | 266 | 0.070 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 2224 | 0.070 |
Why?
|
| Obesity | 3 | 2015 | 2904 | 0.070 |
Why?
|
| Glucose | 2 | 2023 | 1218 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2011 | 676 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 50 | 0.070 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 56 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2020 | 2828 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 81 | 0.070 |
Why?
|
| Adult | 7 | 2024 | 82040 | 0.070 |
Why?
|
| United States | 2 | 2020 | 15861 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 2903 | 0.060 |
Why?
|
| Health Promotion | 1 | 2007 | 510 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Accelerometry | 1 | 2022 | 58 | 0.050 |
Why?
|
| Health Behavior | 1 | 2007 | 601 | 0.050 |
Why?
|
| Social Support | 1 | 2005 | 590 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2024 | 300 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 236 | 0.040 |
Why?
|
| Exercise | 1 | 2007 | 1184 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2022 | 17061 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1477 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 4372 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 241 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 38 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 147 | 0.040 |
Why?
|
| Time Factors | 2 | 2024 | 13006 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 360 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2022 | 1154 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 400 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 376 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 1608 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 342 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2015 | 6 | 0.030 |
Why?
|
| Androgens | 1 | 2018 | 506 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 827 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 618 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 13414 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 741 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 592 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 3404 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2014 | 28 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 33 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 15218 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 113 | 0.030 |
Why?
|
| Testosterone | 1 | 2018 | 638 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2345 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 1267 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 661 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 26 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 1307 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2010 | 91 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 123 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2010 | 249 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 5457 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 196 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 314 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 1228 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 5056 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 5162 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 53 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 237 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 102 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2007 | 70 | 0.020 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 260 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 562 | 0.020 |
Why?
|
| Magnesium | 1 | 2006 | 170 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6867 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 135 | 0.020 |
Why?
|
| Community Health Services | 1 | 2007 | 128 | 0.020 |
Why?
|
| Prednisone | 1 | 2009 | 1034 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 214 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 39890 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 2184 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 280 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 349 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1591 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2009 | 617 | 0.020 |
Why?
|
| Health Education | 1 | 2007 | 303 | 0.020 |
Why?
|
| Minority Groups | 1 | 2007 | 328 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 444 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 1583 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2007 | 603 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 205 | 0.010 |
Why?
|
| Texas | 2 | 2007 | 6449 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12541 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2009 | 1516 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2003 | 68 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2006 | 605 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2010 | 882 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 1305 | 0.010 |
Why?
|
| Remission Induction | 1 | 2008 | 3656 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 1986 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 22505 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 973 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 442 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2015 | 33737 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2006 | 844 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1578 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 90352 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 1235 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 73333 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 5681 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 5923 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 4831 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 8130 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8699 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 10400 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 14617 | 0.000 |
Why?
|